FDA Statistics Are In
1999 Application and Approval Numbers
Rockville, MD-More new drugs have been approved by the Food and Drug Administration (FDA) for the U.S. market in a shorter time period than in the past. The FDA approved 83 drug applications with a median approval time of 12.0 months in 1999. This is compared to a median approval time of 12.0 months in 1998, 14.4 months in 1997 and 15.4 months in 1996. Twenty-eight of the approvals in 1999 were for priority drugs that were approved in a median time of 6.1 months. The priority and regular approvals in 1999 included 35 new molecular entities that were approved in a median time of 11.6 months compared to a median 12.0 months in 1998 and 13.4 months in 1997.
Twenty-four user fee and non-user fee product license applications were approved in a median time of 8.37 months in 1999. Three approvals were categorized as priority and were approved in a median time of 13.8 months. A total of thirty-nine new product license applications were received for review in 1999, 10 more than were received in 1998.
Forty-one premarket approval applications were approved in the median time of 9.1 months in 1999.
IDEA in Action: A Strategic Approach to Contamination Control
January 14th 2025Adopting IDEA—identify, define, explain, apply—streamlines contamination control. Infection control professionals can mitigate risks through prevention, intervention, and training, ensuring safer health care environments and reducing frequent contamination challenges.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.
